Go to deals
Healthcare | Logistics

The Blood Alliance has merged with OneBlood

The Blood Alliance (TBA) has merged with OneBlood. Financial details have not been disclosed.

The Blood Alliance is a non-profit community bloodcenter that provides blood to more than 30 hospitals and medical facilities in Florida, Georgia, and South Carolina. It provides a safe and adequate blood supply to the regions it serves and is a member of America’s Blood Centers – a national network of independent community blood centers responsible for nearly half of the nation’s blood supply. TBA has been enriching lives since 1942 and is licensed by the FDA and accredited by the AABB.

Based in Orlando, Florida, OneBlood, which was formed as the result of a merger of three blood banks in 2012, is a community blood bank serving the Tampa Bay area, south and southeast Florida, the Orlando metropolitan area and surrounding central Florida counties, parts of southwest Florida, Pensacola and Tallahassee and some parts of southern Georgia and Alabama.

Oaklins' team in Jacksonville acted as intermediary and financial advisor to The Blood Alliance in this transaction.

Parties

Talk to the deal team

Doug Kravet

Principal
Jacksonville, United States
Oaklins Heritage

Don Wiggins

Principal
Jacksonville, United States
Oaklins Heritage

Related deals

MEDIK Hospital Design Group has been acquired by STERIS
Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more
bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more
SLT has been acquired by Indutrade
Healthcare

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Learn more